Papers by Dan Zhu
4 results
- JACC Asia
Efficacy and Safety of Quarterly Dosing SHR-1918 in Patients With Suboptimally Controlled Hyperlipidemia
Randomised trial in 44 peopleHyperlipidemia - ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of Oral Ribupatide (HRS9531) in Adults with Obesity: A Phase 2 Trial
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
Efficacy and Safety of a Novel Dual GLP-1/GIP Receptor Agonist (HRS9531), in Obese Adults without Diabetes—Up to 52-Week Treatment
Trial in peopleInterventions